Stem Therapeutics Inc.
Fiscal year ending 2024. Filed on April 13, 2025.
4537 45th St
San Diego, California 92115
Stem Therapeutics Inc. (EIN: 99-3860559) has filed an IRS Form 990 in fiscal year 2024. In its fiscal year 2024 IRS Form 990 filing, Stem Therapeutics Inc., a 501(c)(3) charitable organization, reported compensation for 3 employees. Among the employees shown here, the average compensation is $20. The highest compensated employee at Stem Therapeutics Inc. is Anthony Conway with fiscal year 2024 compensation of $20.
Revenue, expenses, and employee compensation
Revenue
Expenses
Employee compensation
Mission Statement
The mission of Stem Therapeutics, Inc. is to develop universal stem cell-derived cellular therapies to treat diverse cancer patients with high unmet medical need to enable increased access to effective and safe cancer cell therapies close to home (the "Mission"). Stem Therapeutics is exempt under 501(c)(3) with public charity status of 170(b)(1)(A)(vi).
Revisions to this organization profile
Get an email when new compensation information is released for Stem Therapeutics Inc.
Be the first to know when new IRS Form 990 data is published for this organization.